Healthcare & Medical Devices Global On demand · 24-48h

Global Intermittent Catheters Market Strategic Research Report

Global Intermittent Catheters Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Intermittent Catheters Market
$2.83B2025
9.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PVC Intermittent Catheters, Silicone Intermittent Catheters, Red Rubber Intermittent Catheters, Others

By Application: Male Patients, Female Patients, Children

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Coloplast, Wellspect, Bard Medical, Hollister, ConvaTec, Medtronic, Teleflex, B.Braun, Medline Industries, Cure Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 100 pages
Market size 2025
$2.83B
Billion USD
Forecast CAGR
9.9%
2025-2032
Forecast 2032
$5.5B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Intermittent Catheters market size is predicted to grow from US$ 2,832 million in 2025 to US$ 5,431 million in 2032; it is expected to grow at a CAGR of 9.9% from 2026 to 2032.

Urinary catheters are hollow, partially flexible tubes that collect urine from the bladder. Urinary catheters come in many sizes and types. There are three main types of catheters including: Indwelling Catheters (Urethral or Suprapubic Catheters), External Catheters (Condom Catheters) and Short-Term (Intermittent) Catheters. Intermittent catheters are intended to be used to provide an intermittent pathway for short term drainage of fluids from the bladder for either male (Nelaton and Tiemann) and female (Female) or for intravesical instillation.

The major players in global Intermittent Catheters market include Coloplast, Wellspect, Bard Medical, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy about 80% of the global market. PVC Intermittent Catheters is the main type, with a share about 40%. Male Patients is the main application, which holds a share about 45%.

​The intermittent catheters market is experiencing steady growth, influenced by various factors and trends:​

Rising Urinary Disorders: An increase in urinary diseases and conditions like urinary incontinence and neurogenic bladder disorders is boosting the demand for intermittent catheters. ​

Aging Population: The expanding elderly demographic, more susceptible to urological issues, is contributing to market growth.​

Preference for Minimally Invasive Procedures: There's a growing inclination towards less invasive treatments, enhancing the adoption of intermittent catheters.​

Technological Advancements: Innovations in catheter design, such as hydrophilic coatings and antimicrobial properties, are improving patient comfort and reducing infection risks.​

Home Healthcare Expansion: The shift towards home-based care is increasing the use of intermittent catheters, as patients seek convenient solutions for managing urological conditions.​

Sustainability Focus: Manufacturers are exploring eco-friendly materials and production methods to address environmental concerns.

This report presents a comprehensive overview of the global Intermittent Catheters market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PVC Intermittent Catheters
  • Silicone Intermittent Catheters
  • Red Rubber Intermittent Catheters
  • Others

Segment by Application

  • Male Patients
  • Female Patients
  • Children

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intermittent Catheters market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Male Patients, Female Patients, Children evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Intermittent Catheters Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.83B
2025
Forecast
$5.5B
2032
CAGR
9.9%
2025–2032
Regions
5
global
Key companies
ColoplastWellspectBard MedicalHollisterConvaTecMedtronicTeleflexB.Braun
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PVC Intermittent CathetersSilicone Intermittent CathetersRed Rubber Intermittent CathetersOthers
By Application
Male PatientsFemale PatientsChildren

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PVC Intermittent Catheters
  • 3.1.3 Silicone Intermittent Catheters
  • 3.1.4 Red Rubber Intermittent Catheters
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Male Patients
  • 4.1.3 Female Patients
  • 4.1.4 Children
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Coloplast
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Wellspect
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Bard Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hollister
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 ConvaTec
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Medtronic
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Teleflex
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 B.Braun
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Medline Industries
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Cure Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Intermittent Catheters market?
The global Intermittent Catheters market is estimated at US$ 2.83 billion in 2025 (base year) and is projected to reach US$ 5.43 billion by 2032.
How fast is the Intermittent Catheters market expected to grow?
The market is expected to grow at a CAGR of 9.9% from 2026 to 2032, expanding from US$ 2.83 billion in 2025 to US$ 5.43 billion in 2032, roughly 1.9 times its base-year value.
What does the Intermittent Catheters market cover?
Urinary catheters are hollow, partially flexible tubes that collect urine from the bladder. Urinary catheters come in many sizes and types. There are three main types of catheters including: Indwelling Catheters (Urethral or Suprapubic Catheters), External Catheters (Condom Catheters) and Short-Term (Intermittent) Catheters.
How is the Intermittent Catheters market segmented by type?
By type, the market is segmented into PVC Intermittent Catheters, Silicone Intermittent Catheters, Red Rubber Intermittent Catheters and Others.
What are the key applications of Intermittent Catheters?
Key applications covered include Male Patients, Female Patients and Children.
Which companies are profiled in the Intermittent Catheters market report?
Key players profiled include Coloplast, Wellspect, Bard Medical, Hollister, ConvaTec, Medtronic, Teleflex and B.Braun, among 10 companies covered in total.
What geographies does the Intermittent Catheters market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Intermittent Catheters market report?
The report is intended for manufacturers and solution providers, distributors and end users in Male Patients, Female Patients and Children, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Intermittent Catheters market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.